Skip to main content
. 2021 Mar 15;11:638357. doi: 10.3389/fonc.2021.638357

Figure 2.

Figure 2

Clinical applications of sEVs TAA, tumor-associated antigens; DAMPs, damage-associated molecular patterns; NKG2D, Natural Killer Group 2D receptor ligands.